Sympatho-excitatory and hypertensive responses to central infusion of Na + rich aCSF are enhanced by aldosterone and mediated by mineralocorticoid receptors (MR) and benzamil blockable Na + influx leading to "ouabain" release and AT 1 -receptor stimulation.
Introduction
Intra-cerebroventricular (icv) infusion of Na + rich artificial cerebrospinal fluid (aCSF)
activates central nervous system (CNS) pathways leading to sympathetic hyperactivity and hypertension, and these responses can be enhanced by icv infusion of aldosterone (36) . Icv infusion of Fab fragments that specifically bind ouabain-like compounds ("ouabain") (31) blocks these responses whereas icv infusion of spironolactone or benzamil inhibits increases in brain "ouabain" and hypertension in response to chronic icv infusion of Na + rich aCSF (12, 36, 37) . These findings suggest that mineralocorticoid receptors (MR) and benzamil blockable Na + channels or transporters in the CNS mediate release of "ouabain" and the hypertension caused by a chronic increase in CSF [Na + ].
The sympatho-excitatory and hypertensive responses to icv infusion of Na + rich aCSF or ouabain can also be inhibited by icv losartan (13) . Altogether, these results suggest that in response to a chronic increase in CSF [Na + ], increased binding of an endogenous agonist (presumably aldosterone) (15) to MR mediates activation of benzamil blockable Na + influx leading to "ouabain" release and AT 1 -receptor stimulation. Where and how in the CNS these mechanisms interact, has not yet been studied. Immunohistochemical studies also showed dense "ouabain" immunoreactivity throughout the PVN, predominantly in magnocellular neuronal somata and axons closely associated with parvocellular neurons (39, 40) . Angiotensinergic fibers and cell bodies, and AT 1 - receptors are also present in the PVN (24, 27) . Microinjections of angiotensin II (Ang II) or ouabain in the PVN cause increases in BP and HR (18, 42) . AT 1 -receptor stimulation in the PVN may excite subpopulations of PVN neurons innervating presympathetic neurons in the rostral ventrolateral medulla (RVLM) thereby increasing sympathetic activity, BP and HR (6) .
We hypothesized firstly that the mechanisms mediating pressor responses caused by an interstitial [Na + ] ↑ in the PVN would be analogous to the mechanisms involved in CSF sodium-induced hypertension, specifically MR, benzamil blockable Na + influx and "ouabain" release leading to enhanced AT 1 -receptor stimulation and secondly, that these mechanisms in the PVN contribute to the pressor responses to icv infusion of Na + rich aCSF. Accordingly, we assessed the role of different neuromodulators (aldosterone, ouabain) and neurotransmitters (Ang II) in the PVN in the hemodynamic responses to direct infusion into the PVN or icv infusion of Na + rich aCSF. Various blockers were 
Materials and Methods

Animals
Male Wistar rats (250-350 g) were obtained from Charles River Breeding Laboratories, Montreal, Quebec, Canada. The rats were provided with a standard commercial rat chow and water ad libitum. All experiments were carried out according to the guidelines of the Canadian Council on Animal Care, which conform to NIH guidelines and was approved by the University of Ottawa Animal Care and Use Committee. Experiments were conducted after animals were acclimatized for 1 week.
Surgical Procedures
For all surgeries, rats were anesthetized with 2% isoflurane in oxygen. Animals were placed in a stereotaxic head frame, and the skull was leveled between bregma and lambda. For experiments involving infusion of Na + rich aCSF in the PVN, a section of the skull was removed, and a guide cannula (23 gauge) was positioned unilaterally 0.5 mm above the PVN according to the rat atlas of Paxinos and Watson (30), 1.8 mm posterior to bregma, 0.4 mm lateral to the bregma and 7.9 mm ventral from the skull. For combined icv and PVN experiments, guide cannulas were positioned bilaterally 0.5 mm above the PVN and unilaterally above the left lateral cerebral ventricle at 0.4 mm caudal to bregma, 1.4 mm lateral to bregma and 3.5 mm ventral to dura (30) . Guide cannulas were secured to the skull with two jeweler's screws and acrylic cement and closed with stainless steel obturators. After 1 week recovery, the left femoral artery was cannulated with PE-50/10 polyethylene tubing filled with heparin (1,000 U/ml in 0.9% NaCl). For withdrawal of CSF, on the day of the experiment, rats were placed in the stereotaxic head frame and a cannula was inserted into the cisterna magna, as described previously (14) .
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Experimental Procedures
The morning after placement of the arterial line, rats were placed in a small cage and intra-arterial catheters were connected to a pressure transducer for recordings of BP and HR via a PC equipped with software AcqKnowledge (ACQ 3.2). Systolic and diastolic pressures were determined from the raw BP signal and mean arterial pressure (MAP) was determined by adding one third of the pulse pressure to the diastolic pressure.
An "L"-shaped injection cannula (30 gauge) was lowered into the lateral ventricle or PVN through the fixed guide cannula and extended 0.5 mm past the guide. For PVN and icv infusions, injection cannulas were connected by polyethylene tubing to 10 or 500
μL Hamilton microsyringes mounted on a Harvard infusion pump (model #2400-003).
Micro-injections of 100 nL were conducted for 3-5 s using a 1 uL Hamilton microsyringe. For all experiments, animals were allowed to settle and baseline levels were recorded after 20 min of stabilization and after different pretreatments before infusion of Na + rich aCSF. None of the pretreatments caused persistent changes in BP or HR (Table 1) . At the end of the experiment, rats were euthanized with carbon dioxide and injected with 100 nL Evans Blue dye. Brains were removed, fixed in 2-methylbutane at -20 o C, sectioned (30 µm) using a Leica cryostat and stained with neutral red.
The extent of tissue damage from the cannula in the PVN was limited to the diameter of the circular injection cannula lowered into the PVN and was similar after 5 and 15 min infusion at 300 nL/min (Fig. 1A) . Micro-injection sites marked with Evans Blue were identified with a light microscope, and only data of rats whose micro-injection sites were within the lateral ventricle and the PVN were used for analysis. Correct injection sites ranged from 70-90 % for groups with unilateral infusions into the PVN and from 50-70 % found localized within the PVN region after 5 min and 10 min infusion (Fig. 1B) .
Experimental Protocols Vehicles
Artificial cerebrospinal fluid (aCSF: 121 NaCl, 3. To evaluate the role of endogenous "ouabain" in the response to aldosterone and Na + rich aCSF in the PVN, aldosterone was infused into the PVN at 300 ng/300 nL/min for 5 min followed by 45 min recovery. Ouabain-binding Fab fragments (Digibind) (31) or its vehicle were then infused at 2.9 μg/300 nL/min for 3.5 min prior to infusion of Na was infused into the PVN at 300 nL/min for 15 min. In another group of rats, the subpressor dose of ouabain was infused into the PVN prior to infusion of aCSF at 300 nL/min for 15 min.
Vasopressin release and Na + Rich aCSF alone or combined with aldosterone in the PVN:
To evaluate the role of vasopressin in the BP responses to Na + rich aCSF alone, or after aldosterone, aldosterone vehicle or aldosterone (1.5 μg) were infused at 300 nL/min ) was infused at 300 nL/min for 15 min into the PVN. The dose of the vasopressin antagonist was chosen from our previous study (36) . ) was then performed at 3.8 uL/min for 20 min. Telmisartan was used for its longer duration of action and higher binding affinity than losartan (19) . In a subsequent group, icv infusion of aldosterone was performed at 5 ng/3.8 ul/min for 2 hr.
Combined icv and PVN Experimental Protocols
Telmisartan was then infused bilaterally into the PVN followed by icv infusion of Na + rich aCSF, using the same doses as above. ] in 100 ul samples. Standard curves were generated from standard solutions made from aCSF and varying amounts of NaCl.
Statistical Analysis
Values are expressed as means ± SE. The following statistical tests were used: 1) For comparisons among treatments, a one-way analysis of variance (ANOVA) was used followed by a Student-Newman-Keuls post hoc multiple comparison.
2) For comparisons of treatments against control, a one-way ANOVA followed by Dunnett's Infusion of aldosterone caused no significant changes in MAP (0±1 mmHg) and HR (10±1 bpm). After pretreatment with aldosterone, MAP and HR responses to Na + rich aCSF at 0.3 M Na + were significantly increased while there were nearly two-fold increases in both MAP and HR responses to Na + rich aCSF at 0.7 M Na + (Fig. 2,3) . The enhancement by aldosterone of the responses to Na + rich aCSF at 0.7 M Na + was blocked by eplerenone (Fig. 3) .
Results
Studies in the PVN
Aldosterone, benzamil, Fab fragments and Na + rich aCSF: Both benzamil and Fab fragments fully blocked the enhancement by aldosterone of the responses to Na + rich aCSF (Fig. 4) . Benzamil produced similar effects when it was administered by micro-injection alone or by micro-injection followed by infusion (only the latter data shown).
In groups combining aldosterone with benzamil or Fab fragments, increases in MAP and HR by Na + rich aCSF were similar to those by Na + rich aCSF without pretreatment with aldosterone (Fig. 4) .
Ouabain, Ang II, and Losartan dose response studies: Micro-injection of Ang II and ouabain in the PVN caused dose related increases in MAP and HR (Table 2) Losartan in the PVN fully blocked the MAP and HR responses to both Ang II and ouabain (Table 2) .
Aldosterone, losartan and Na + rich aCSF: After aldosterone, Na + rich aCSF caused again significantly larger increases in MAP and HR as compared to Na + rich aCSF alone (Fig. 5) . Losartan fully prevented increases in MAP and HR to Na + rich aCSF either given alone or after aldosterone (Fig. 5) .
Subpressor dose of ouabain and Na + rich aCSF in the PVN: After infusion of a subpressor dose of ouabain in the PVN, MAP and HR responses to infusion of Na + rich aCSF at 0.7 M Na + were significantly larger compared to its effects after infusion of vehicle ( Fig. 6 ), whereas infusion of aCSF in the PVN caused no significant changes in MAP and HR (Fig. 6) .
Vasopressin release and Na + Rich aCSF alone or combined with aldosterone in the PVN:
Infusion of Na + rich aCSF at 0.7 M Na + in the PVN caused the same gradual increases in MAP after iv pretreatment with vehicle (10±2 mmHg) or with AVP antagonist (11±2 mmHg) (Fig. 2) . Peak increases in HR were also the same (vehicle, 40±4 bpm; AVP antagonist, 43±5 bpm), but the initial decrease was no longer observed after iv AVP antagonist (Fig. 2) . The AVP antagonist did not affect the enhancement by aldosterone of the peak MAP and HR responses to Na + rich aCSF at 0.7 M Na + (MAP, 17±2 mmHg;
HR, 64±7 bpm) as compared to aldosterone and Na + rich aCSF alone.
Combined icv and PVN Studies
Icv infusion of Na responses to icv infusion of Na + rich aCSF were significantly increased after icv infusion of aldosterone (Fig. 8) . This enhancement by aldosterone infused icv was not affected by pre-treatment with eplerenone in the PVN (Fig. 8) . Similarly, infusion of benzamil into the PVN did not change the MAP and HR responses to icv infusion of Na + rich aCSF after icv infusion of aldosterone (Fig. 8) . ] ↑ resulting via benzamil blockable Na + influx and "ouabain" release in enhanced AT 1 -receptor stimulation. One may speculate that in the PVN, under basal conditions aldosterone release, and therefore activity of benzamil sensitive Na + channels or transporters and "ouabain" release are low, and a short infusion of Na + rich aCSF does not sufficiently increase this pathway to make a contribution. The present study does not address which Na + channels or transporters specifically mediate the benzamil sensitive Na + influx. However, the amount (100 ng or 0.28 nmol) infused into the PVN with a volume of 0.45±0.03 mm 3 (7), may result in concentrations in the range of 0.5 -2.0 mM, in which one may expect maximal inhibition of ENaC and little inhibition of other channels or transporters (21, 22) . Doses of eplerenone and benzamil delivered to each side of the PVN were also similar to doses that blocked the enhancement by aldosterone of the pressor responses to Na + rich aCSF in the PVN. These findings indicate that MR and benzamil blockable Na + influx in the PVN are not involved in mediating the pressor responses to a short icv infusion of Na + rich aCSF or their enhancement by icv aldosterone. The pressor responses to icv infusion of aldosterone and Na + rich aCSF are mediated by benzamil blockable Na + channels or transporters in the brain since they can be blocked by icv infusion of benzamil (36, 37) . We conclude from these findings that other brain regions with a more sensitive MR -benzamil sensitive Na + influx -"ouabain" system mediate the responses to CSF [Na + ] ↑. Indeed, the pressor responses to icv infusion of Na + rich aCSF were completely abolished by Fab fragments in the median preoptic nucleus (MnPO)
Icv infusion of Na
Role of PVN in Responses to
demonstrating that "ouabain" in the MnPO mediates the cardiovascular responses to icv infusion of Na + rich aCSF (4). Alternatively, it is possible that a short icv infusion of Na 
Limitations of the Present Study
Some limitations of the present study should be considered. Firstly, the actual local concentrations of Na + or aldosterone achieved in the PVN or general CSF depend on the amount infused relative to the volume of distribution and turnover of the volume. 
Perspectives and Significance
The present findings indicate that AT 1 Values are mean ± SEM 
